Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia.: The Polish Adult Leukemia Group ALL 4-2002 MRD Study
BRITISH JOURNAL OF HAEMATOLOGY (2008)
期刊
BRITISH JOURNAL OF HAEMATOLOGY
卷 142, 期 2, 页码 227-237出版社
WILEY
关键词
类别
作者
我是这篇论文的作者
推荐
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study
Martijn W. C. Verbeek, Chiara Buracchi, Anna Laqua, Stefan Nierkens, Lukasz Sedek, Juan Flores-Montero, Mattias Hofmans, Elaine Sobral de Costa, Michaela Novakova, Ester Mejstrikova, Susana Barrena, Saskia Kohlscheen, Monika Szczepanowski, Jan Kulis, Elen Oliveira, Romana Jugooa, Anja X. de Jong, Tomasz Szczepanski, Jan Philippe, Jacques J. M. Van Dongen, Alberto Orfao, Monika Brueggemann, Giuseppe Gaipa, Vincent H. J. Van der Velden
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Minimal residual disease level determined by flow cytometry provides reliable risk stratification in adults with T-cell acute lymphoblastic leukaemia
Huanping Wang, Yile Zhou, Xin Huang, Yi Zhang, Jiejing Qian, Jianhu Li, Chenying Li, Xueying Li, Yinjun Lou, Qiaoyun Zhu, Yujie Huang, Haitao Meng, Wenjuan Yu, Hongyan Tong, Jie Jin, Hong-Hu Zhu
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Comparison of minimal residual disease measurement by multicolour flow cytometry and PCR for fusion gene transcripts in infants with acute lymphoblastic leukaemia with KMT2A gene rearrangements
Alexander Popov, Grigory Tsaur, Tatiana Verzhbitskaya, Tatiana Riger, Zhan Permikin, Anna Demina, Ekaterina Mikhailova, Egor Shorikov, Oleg Arakaev, Olga Streneva, Olga Khlebnikova, Olga Makarova, Natalia Miakova, Veronika Fominikh, Elmira Boichenko, Konstantin Kondratchik, Natalia Ponomareva, Galina Novichkova, Alexander Karachunskiy, Larisa Fechina
BRITISH JOURNAL OF HAEMATOLOGY (2023)
The shape of cancer relapse: Topological data analysis predicts recurrence in paediatric acute lymphoblastic leukaemia
Salvador Chulian, Bernadette Stolz, Alvaro Martinez-Rubio, Cristina Blazquez Goni, Juan Rodriguez Gutierrez, Teresa Caballero Velazquez, Agueda Molinos Quintana, Manuel Ramirez Orellana, Ana Castillo Robleda, Jose Luis Fuster M. Soler, Alfredo Minguela Puras, Maria V. Martinez D. Sanchez, Maria D. Rosa, Victor M. D. Perez-Garcia, Helen D. Byrne
PLOS COMPUTATIONAL BIOLOGY (2023)
Minimal Residual Disease in Acute Lymphoblastic Leukemia: Current Practice and Future Directions
Gloria Paz Contreras Yametti, Talia H. Ostrow, Sylwia Jasinski, Elizabeth A. Raetz, William L. Carroll, Nikki A. Evensen
CANCERS (2021)
Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy
Ekaterina Mikhailova, Olga Illarionova, Alexander Komkov, Elena Zerkalenkova, Ilgar Mamedov, Larisa Shelikhova, Yulia Olshanskaya, Natalia Miakova, Galina Novichkova, Alexander Karachunskiy, Michael Maschan, Alexander Popov
CANCERS (2022)
Relative expansion of CD19-negative very-early normal B-cell precursors in children with acute lymphoblastic leukaemia after CD19 targeting by blinatumomab and CAR-T cell therapy: implications for flow cytometric detection of minimal residual disease
Ekaterina Mikhailova, Alexandra Semchenkova, Olga Illarionova, Svetlana Kashpor, Varvara Brilliantova, Elena Zakharova, Elena Zerkalenkova, Andrea Zangrando, Natalia Bocharova, Larisa Shelikhova, Yulia Diakonova, Vladimir Zhogov, Rimma Khismatullina, Olga Molostova, Barbara Buldini, Elena Raykina, Sergey Larin, Yulia Olshanskaya, Natalia Miakova, Galina Novichkova, Michael Maschan, Alexander M. Popov
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Mimics and artefacts of measurable residual disease in a highly sensitive multicolour flow cytometry assay for B-lymphoblastic leukaemia/lymphoma: critical consideration for analysis of measurable residual disease
Gaurav Chatterjee, Harshini Sriram, Sitaram Ghogale, Nilesh Deshpande, Twinkle Khanka, Karishma Girase, Shefali Verma, Gauri Arolkar, Niharika Dasgupta, Gaurav Narula, Dhanalaxmi Shetty, Chetan Dhamne, Nirmalya R. Moulik, Sweta Rajpal, Nikhil Patkar, Shripad Banavali, Sumeet Gujral, Papagudi G. Subramanian, Prashant R. Tembhare
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Minimal residual disease (MRD) detection in acute lymphoblastic leukaemia based on fusion genes and genomic deletions: towards MRD for all
Roland P. Kuiper, Patricia G. Hoogeveen, Reno Bladergroen, Freerk van Dijk, Edwin Sonneveld, Frank N. van Leeuwen, Judith Boer, Irina Sergeeva, Harma Feitsma, Monique L. den Boer, Vincent H. J. van der Velden
BRITISH JOURNAL OF HAEMATOLOGY (2021)
An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report
Margarita Maurer-Granofszky, Angela Schumich, Barbara Buldini, Giuseppe Gaipa, Janos Kappelmayer, Ester Mejstrikova, Leonid Karawajew, Jorge Rossi, Adin cinar Suzan, Evangelina Agriello, Theodora Anastasiou-Grenzelia, Virna Barcala, Gabor Barna, Drago Batinic, Jean-Pierre Bourquin, Monika Brueggemann, Karolina Bukowska-Strakova, Hasan Burnusuzov, Daniela Carelli, Guennur Deniz, Klara Dubravcic, Tamar Feuerstein, Marie Isabel Gaillard, Adriana Galeano, Hugo Giordano, Alejandro Gonzalez, Stefanie Groeneveld-Krentz, Zsuzsanna Hevessy, Ondrej Hrusak, Maria Belen Iarossi, Pal Jakso, Veronika Kloboves Prevodnik, Saskia Kohlscheen, Elena Kreminska, Oscar Maglia, Cecilia Malusardi, Neda Marinov, Bibiana Maria Martin, Claudia Moeller, Sergey Nikulshin, Jorge Palazzi, Georgios Paterakis, Alexander Popov, Richard Ratei, Cecilia Rodriguez, Elisa Olga Sajaroff, Simona Sala, Gordana Samardzija, Mary Sartor, Pamela Scarparo, Lukasz Sedek, Bojana Slavkovic, Liliana Solari, Peter Svec, Tomasz Szczepanski, Anna Taparkou, Montserrat Torrebadell, Marianna Tzanoudaki, Elena Varotto, Helly Vernitsky, Andishe Attarbaschi, Martin Schrappe, Valentino Conter, Andrea Biondi, Marisa Felice, Myriam Campbell, Csongor Kiss, Giuseppe Basso, Michael N. Dworzak
CANCERS (2021)
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia
Josep-Maria Ribera, Mireia Morgades, Juana Ciudad, Pau Montesinos, Jordi Esteve, Eulalia Genesca, Pere Barba, Jordi Ribera, Irene Garcia-Cadenas, Maria Jose Moreno, Daniel Martinez-Carballeira, Anna Torrent, Pilar Martinez-Sanchez, Silvia Monsalvo, Cristina Gil, Mar Tormo, Maria Teresa Artola, Marta Cervera, Jose Gonzalez-Campos, Carlos Rodriguez, Arancha Bermudez, Andres Novo, Beatriz Soria, Rosa Coll, Maria-Luz Amigo, Aurelio Lopez-Martinez, Rosa Fernandez-Martin, Josefina Serrano, Santiago Mercadal, Antonia Cladera, Alberto Gimenez-Conca, Maria-Jesus Penarrubia, Eugenia Abella, Ferran Vall-llovera, Jesus-Maria Hernandez-Rivas, Antoni Garcia-Guinon, Juan-Miguel Bergua, Beatriz de Rueda, Maria-Jose Sanchez-Sanchez, Alfons Serrano, Maria Calbacho, Natalia Alonso, Jose-Angel Mendez-Sanchez, Raimundo Garcia-Boyero, Matxalen Olivares, Susana Barrena, Lurdes Zamora, Isabel Granada, Ludovic Lhermitte, Evarist Feliu, Alberto Orfao
BLOOD (2021)
Immunophenotype of Measurable Residual Blast Cells as an Additional Prognostic Factor in Adults with B-Cell Acute Lymphoblastic Leukemia
Yulia Davydova, Irina Galtseva, Nikolay Kapranov, Ksenia Nikiforova, Olga Aleshina, Yulia Chabaeva, Galina Isinova, Ekaterina Kotova, Andrey Sokolov, Vera Troitskaya, Sergey Kulikov, Elena Parovichnikova
DIAGNOSTICS (2023)
A simple procedure to identify children with B-lineage acute lymphoblastic leukemia who can be successfully treated with low or moderate intensity: Sequential versus single-point minimal residual disease measurement
Alexander Popov, Guenter Henze, Julia Roumiantseva, Oleg Budanov, Mikhail Belevtsev, Tatiana Verzhbitskaya, Elena Boyakova, Liudmila Movchan, Grigory Tsaur, Maria Fadeeva, Svetlana Lagoyko, Liudmila Zharikova, Natalia Miakova, Dmitry Litvinov, Olga Khlebnikova, Olga Streneva, Elena Stolyarova, Natalia Ponomareva, Galina Novichkova, Larisa Fechina, Olga Aleinikova, Alexander Karachunskiy
PEDIATRIC BLOOD & CANCER (2023)
Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant
Cyril Salek, Frantisek Folber, Eva Fronkova, Pavla Pecherkova, Hana Jelinkova, Stepan Hrabovsky, Jan M. Horacek, Petr Cetkovsky, Jiri Mayer, Jan Trka, Michael Doubek
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Measurable Residual Disease (MRD) by Flow Cytometry in Adult B-Acute Lymphoblastic Leukaemia (B-ALL) and Acute Myeloid Leukaemia (AML): Correlation with Molecular MRD Testing and Clinical Outcome at One Year
Riana van der Linde, Prudence N. Gatt, Sandy Smith, Marian A. Fernandez, Lachlin Vaughan, Emily Blyth, Jennifer Curnow, David A. Brown, Elizabeth Tegg, Sarah C. Sasson
CANCERS (2023)
Total body irradiation plus fludarabine compared to busulfan plus fludarabine as reduced-toxicity conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT
Sebastian Giebel, Myriam Labopin, Malgorzata Sobczyk-Kruszelnicka, Matthias Stelljes, Jenny L. Byrne, Nathalie Fegueux, Dietrich W. Beelen, Montserrat Rovira, Alexandros Spyridonidis, Didier Blaise, Martin Bornhaeuser, Ihsan Karadogan, Bipin N. Savani, Arnon Nagler, Mohamad Mohty, Sonja Martin, Patrice Chevallier, Andreas Neubauer, Gandhi Damaj, Yener Koc, Arnold Ganser, Matthew Collin, Ibrahim Yakoub-Agha, Hakan Ozdogu, Mercedes Colorado Araujo, Maija Itala-Remes, Kim Orchard, Cecilia Isaksson, Wolfgang Bethge, Hans Martin, Mahmoud Aljurf, Edgar Faber, Dolores Caballero, Pavel Zak, Xavier Leleu, Jacques-Olivier Bay, Pierre-Simon Rohrlich, Nicolaus Kroeger, Anne Huynh, Kerstin Schaefer-Eckart, Noel Milpied, Stig Lenhoff, Aloysius Ho, Jose Luis Bello Lopez, Nicola Mordini, Bruno Lioure, Kazimierz Halaburda, Attilio Olivieri, Tobias Gedde-Dahl, Rachel Protheroe, Johanna Tischer, Matthias Klammer, Johannes Clausen, Victoria Potter, Marco Ladetto, Herve Tilly, Eric Deconinck, Arne Brecht, Lutz Peter Mueller, Thomas Heinicke, Juan Pio Torres Carrete, Ali Bazarbachi, Peter Remenyi, Marie Therese Rubio, Renato Fanin, Jose Antonio Perez-Simon, Murawski Niels, J. L. Diez-Martin, Mutlu Arat, Olivier Hermine, Gerard Socie, Jan J. Cornelissen, Stella Santarone, Denis Guyotat, Claude Eric Bulabois, Paolo Bernasconi, Jan-Erik Johansson, Radovan Vrhovac, Hildegard Greinix, Jose Luis Lopez Lorenzo, Shashikant Apte, Charles Craddock, Guido Kobbe, Mohsen Al Zahrani, Peter Dreger, Andrzej Lange, Abdelghani Tbakhi, Ellen Meijer, Carlos Vallejo Llamas, Josep Maria Ribera Santasusana, Paolo Corradini, Fabio Benedetti, Alessandro Rambaldi, Virginie Gandemer, Jean-Valere Malfuson, Ain Kaare, Antonio Risitano, Mario Petrini, Carmine Selleri, Depei Wu
BONE MARROW TRANSPLANTATION (2021)
Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party
Klaus Hirschbuehl, Myriam Labopin, Mohamed Houhou, Ludovic Gabellier, Helene Labussiere-Wallet, Bruno Lioure, Dietrich Beelen, Jan Cornelissen, Gerald Wulf, Pavel Jindra, Herve Tilly, Jakob Passweg, Riita Niittyvuopio, Gesine Bug, Christoph Schmid, Arnon Nagler, Sebastian Giebel, Mohamad Mohty
BONE MARROW TRANSPLANTATION (2021)
Tandem autologous hematopoietic cell transplantation with sequential use of total marrow irradiation and high-dose melphalan in multiple myeloma
Sebastian Giebel, Malgorzata Sobczyk-Kruszelnicka, Slawomir Blamek, Maria Sadus-Wojciechowska, Jacek Najda, Tomasz Czerw, Wlodzimierz Mendrek, Grzegorz Wozniak, Bozena Jochymek, Michal Radwan, Wojciech Leszczynski, Lukasz Dolla, Andrea D'Amico, Krzysztof Slosarek, Jerzy Holowiecki, Leszek Miszczyk
BONE MARROW TRANSPLANTATION (2021)
The Prognostic Value of Early Measurable Residual Disease Assessment in Patients with Acute Myeloid Leukemia Treated with Intensive Chemotherapy - Preliminary Results of Polish Adult Leukemia Group PALG-AML1/2016 Study
Agnieszka Wierzbowska, Agnieszka Pluta, Anna Czyz, Marta Antonina Libura, Sebastian Giebel, Magdalena Czemerska, Piotr Stelmach, Michal Soin, Anna Kopinska, Krzysztof Wozniczka, Grzegorz Helbig, Marta Sobas, Tomasz Wrobel, Andrzej Szczepaniak, Lidia Gil, Karol Wojcik, Malgorzata Razny, Magdalena Dutka, Maria Bieniaszewska, Janusz Halka, Tomasz Gromek, Marek Hus, Elzbieta Patkowska, Jolanta Wozniak, Edyta Cichocka, Agata Obara, Agnieszka Kopacz, Katarzyna Dulik, Jerzy Holowiecki, Damian Mikulski, Ewelina Perdas, Wojciech Fendler, Nicole M. Cruz, Nuria Mencia-Trinchant, Pinkal Desai, Sangmin Lee, Michael B. Samuel, Justin D. Kaner, Ellen Ritchie, Monica L. Guzman, Gail J. Roboz
BLOOD (2021)
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
Michael Heuser, Sylvie D. Freeman, Gert J. Ossenkoppele, Francesco Buccisano, Christopher S. Hourigan, Lok Lam Ngai, Jesse M. Tettero, Costa Bachas, Constance Baer, Marie-Christine Bene, Veit Bucklein, Anna Czyz, Barbara Denys, Richard Dillon, Michaela Feuring-Buske, Monica L. Guzman, Torsten Haferlach, Lina Han, Julia K. Herzig, Jeffrey L. Jorgensen, Wolfgang Kern, Marina Y. Konopleva, Francis Lacombe, Marta Libura, Agata Majchrzak, Luca Maurillo, Yishai Ofran, Jan Philippe, Adriana Plesa, Claude Preudhomme, Farhad Ravandi, Christophe Roumier, Marion Subklewe, Felicitas Thol, Arjan A. van de Loosdrecht, Bert A. van der Reijden, Adriano Venditti, Agnieszka Wierzbowska, Peter J. M. Valk, Brent L. Wood, Roland B. Walter, Christian Thiede, Konstanze Dohner, Gail J. Roboz, Jacqueline Cloos
BLOOD (2021)
Two Doses of BNT162b2 mRNA Vaccine in Patients after Hematopoietic Stem Cell Transplantation: Humoral Response and Serological Conversion Predictors
Maciej Majcherek, Agnieszka Matkowska-Kocjan, Donata Szymczak, Magdalena Karasek, Agnieszka Szeremet, Aleksandra Kiraga, Aneta Milanowska, Edwin Kuznik, Krzysztof Kujawa, Tomasz Wrobel, Leszek Szenborn, Anna Czyz
CANCERS (2022)
Harmonization of Flow Cytometric Minimal Residual Disease Assessment in Multiple Myeloma in Centers of Polish Myeloma Consortium
Agnieszka Krzywdzinska, Bartosz Pula, Anna Czyz, Beata Krzymieniewska, Jolanta Kiernicka-Parulska, Anna Mierzwa, Donata Szymczak, Aneta Milanowska, Aleksandra Kiraga, Iwona Kwiecien, Joanna Zaleska, Krzysztof Jamroziak
DIAGNOSTICS (2021)
Validation of thrombotic risk factors in 1381 patients with essential thrombocythaemia: A multicentre retrospective real-life study
Ruth Stuckey, Jean-Christophe Ianotto, Marco Santoro, Anna Czyz, Manuel M. Perez Encinas, Maria Teresa Gomez-Casares, Maria Soledad Noya Pereira, Anna Kulikowska de Nelecz, Aleksandra Golos, Krzysztof Lewandowski, Lukasz Szukalski, Jesus M. Gonzalez-Martin, Tomasz Wrobe, Marta Anna Sobas
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Pre-Transplant Multiparameter Flow Cytometric Measurable Residual Disease in Acute Myeloid Leukemia As an Independent Prognostic Factor for Survival after Myeloablative Allogeneic Hematopoietic Cell Transplantation
Anna Czyz, Malgorzata Maria Sobczyk Kruszelnicka, Tomasz Czerw, Sebastian Giebel, Magdalena Dutka, Agnieszka Piekarska, Maria Bieniaszewska, Jan Zaucha, Maciej Majcherek, Marta Anna Sobas, Tomasz Wrobel, Barbara Nasilowska-Adamska, Halaburda Kazimierz, Andrzej Szczepaniak, Lidia Gil, Anna Kopinska, Grzegorz Helbig, Sylwia Bartyzel-Palinska, Patrycja Mensah-Glanowska, Agnieszka Tomaszewska, Agnieszka Pluta, Elzbieta Patkowska, Jolanta Wozniak, Agnieszka Balana, Donata Szymczak, Jolanta Parulska, Ameenah Sukkur, Andi Rustani, Nuria Mencia Trinchant, Pinkal Desai, Michael Samuel, Justin D. Kaner, Ellen Ritchie, Monica L. Guzman, Gail J. Roboz, Agnieszka Wierzbowska
BLOOD (2022)
Prospective Assessment of Measurable Residual Disease Kinetics in Intensively Treated Patients with Acute Myeloid Leukemia - Results of the Polish Adult Leukemia Group PALG-AML1/2016 Study
Agnieszka Wierzbowska, Agnieszka Pluta, Anna Czyz, Marta Antonina Libura, Sebastian Giebel, Piotr Stelmach, Magdalena Czemerska, Piotr Strzalka, Anna Kopinska, Krzysztof Wozniczka, Grzegorz Helbig, Karol Wojcik, Malgorzata Razny, Marta Anna Sobas, Tomasz Wrobel, Andrzej Szczepaniak, Lidia Gil, Magdalena Dutka, Maria Bieniaszewska, Tomasz Gromek, Marek Hus, Edyta Cichocka, Janusz Halka, Elzbieta Patkowska, Marzena Watek, Jolanta Wozniak, Ewa Lech-Maranda, Agnieszka Kopacz, Katarzyna Dulik, Jerzy Holowiecki, Michal Soin, Damian Mikulski, Ewelina Perdas, Wojciech Fendler, Ameenah Sukkur, Andi Rustani, Nuria Mencia Trinchant, Pinkal Desai, Sangmin Lee, Michael Samuel, Justin D. Kaner, Ellen Ritchie, Monica L. Guzman, Gail J. Roboz
BLOOD (2022)
ATG or no ATG? - survey of clinical practice in EBMT centers on behalf of the Transplant Complications Working Party of EBMT
Agnieszka Piekarska, Anna Czyz, Christophe Peczynski, Pascale Ambron, Emmanuelle Polge, Ivan Moiseev, Helene Schoemans, Olaf Penack, Zinaida Peric, Grzegorz W. Basak
BONE MARROW TRANSPLANTATION (2023)
Differential expression of miRNAs from extracellular vesicles in chronic graft-versus-host disease: A preliminary study
Piotr Lacina, Rachel E. Crossland, Joanna Wielinska, Anna Czyz, Agnieszka Szeremet, Marek Ussowicz, Tomasz Wrobel, Anne M. Dickinson, Katarzyna Bogunia-Kubik
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2023)
Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells
Jagoda Siemaszko, Piotr Lacina, Donata Szymczak, Agnieszka Szeremet, Maciej Majcherek, Anna Czyz, Malgorzata Sobczyk-Kruszelnicka, Wojciech Fidyk, Iwona Solarska, Barbara Nasilowska-Adamska, Patrycja Skowronska, Maria Bieniaszewska, Agnieszka Tomaszewska, Grzegorz W. Basak, Sebastian Giebel, Tomasz Wrobel, Katarzyna Bogunia-Kubik
FRONTIERS IN IMMUNOLOGY (2023)
Epidermal barrier function in patients after allogeneic hematopoietic stem cell transplantation - a pilot study
Adriana Polanska, Anna Lojko-Dankowska, Anna Czyz, Zygmunt Adamski, Ryszard Zaba, Lidia Gil, Aleksandra Danczak-Pazdrowska
POSTEPY DERMATOLOGII I ALERGOLOGII (2022)
Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party
Jesse M. Tettero, Sylvie Freeman, Veit Buecklein, Adriano Venditti, Luca Maurillo, Wolfgang Kern, Roland B. Walter, Brent L. Wood, Christophe Roumier, Jan Philippe, Barbara Denys, Jeffrey L. Jorgensen, Marie C. Bene, Francis Lacombe, Adriana Plesa, Monica L. Guzman, Agnieszka Wierzbowska, Anna Czyz, Lok Lam Ngai, Adrian Schwarzer, Costa Bachas, Jacqueline Cloos, Marion Subklewe, Michaela Fuering-Buske, Francesco Buccisano
HEMASPHERE (2022)